LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.4650
+0.0150 (3.33%)
At close: Jul 31, 2026
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 84.53 million as of July 31, 2026. Its market cap has increased by 35.38% in one year.
Market Cap
84.53M
Enterprise Value
58.75M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.47
ChartMarket Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 84.53M, an increase of 59.55%. That is a compound annual growth rate of 19.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 84.53M | -35.37% |
| Dec 31, 2025 | 130.78M | -10.78% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
| Dec 11, 2023 | 52.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 112.45M |
| Alterity Therapeutics | 110.93M |
| Recce Pharmaceuticals | 109.31M |
| Paradigm Biopharmaceuticals | 96.36M |
| Prescient Therapeutics | 85.17M |
| Avecho Biotechnology | 76.61M |
| Arovella Therapeutics | 76.15M |
| Immutep | 69.26M |